Memsift establishes MOU with CCAST

Dr J Antony Prince, Founder & CEO, Memsift Innovations Pte Ltd (Left) and Dr Jeffrey McCutcheon, Executive Director, CCAST (Right)

Singapore-based Memsift Innovations Pte Ltd and the Connecticut Center for Applied Separations Technologies (CCAST) at the University of Connecticut (UConn) have executed a cooperation agreement in the form of Memorandum of Understanding (MOU) to explore application studies and pilot trials for Memsift technologies in North America. 

Memsift’s thermal separation process and membranes are based on innovative patented technologies that provide unique benefits over traditional brine treatment and zero liquid discharge solutions. Memsift’s TS-30TM system uses an innovative thermodynamic principle based thermal separation process and a proprietary membrane STOMATE® that brings down the industrial effluents treatment cost significantly. Memsift has received interests for its product and its applications from North America. Memsift determined to explore the potential markets and applications for its products in the region. It would be advantageous to appoint a strategic partner who possesses the technical understanding and analytical facilities to perform the application studies and pilot trials to validate the product for its initial customers in the United State of America (USA). 

The Connecticut Center for Applied Separations Technologies at the University of Connecticut is highly regarded in North America for its membrane separation expertise and experience, particularly related to membrane distillation. As a result, CCAST is a strong partner for testing and or validating third-party applications as well as for performing application studies and or pilot trials for North American companies interested in utilising Memsift technologies. This third-party testing service will support Memsift’s commercialisation efforts and early stage adoption in North America. 

Dr J. Antony Prince, founder & CEO, Memsift Innovations said, “This is an important steppingstone for the company to enter the North American market. Through this cooperation, we could be able to bring our cutting-edge technologies to our customers doorstep where they can test the technology easily for different applications. We are expecting to start some pilot trials for the geothermal brine and produced water treatment in North America in the near future. We are very excited about the opportunity to work with this world class research institution to facilitate the real lab and pilot trials for our customers and the subsequent commercial opportunities it presents to the company.” 

Dr. Jeffrey McCutcheon, executive director, CCAST, University of Connecticut, said, “We are excited to team up with Memsift to conduct applications testing on their innovative products. We welcome partnerships like this to expand the availability of emerging technology for water treatment and other separations throughout North America.”